Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program
Articolo
Data di Pubblicazione:
2017
Abstract:
Patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV coinfected patients participating in an Italian compassionate-use program of ombitasvir/ paritaprevir/ritonavir + dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV)
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Anti-HCV therapy; Antiviral therapy; DAA; HIV/HCV coinfection; IFN-free; Microbiology (medical); Infectious Diseases
Elenco autori:
Andreoni, Massimo; Teti, Elisabetta; Antinori, Andrea; Milazzoi, Laura; Sollima, Savatore; Rizzardini, Giuliano; Di Biagio, Antonio; Saracino, Annalisa; Bruno, Raffaele; Borghi, Vanni; De Luca, Andrea; Cattelan, Annamaria; Hasson, Hamid; Taliani, Gloria; Monforte, Antonella D'Arminio; Mastroianni, Claudio Maria; Di Perri, Giovanni; Bigoni, Sara; Puoti, Massimo; Spinetti, Angiola; Gori, Andrea; Boffa, Nicola; Cacopardo, Bruno; Giacometti, Andrea; Parruti, Giustino; Vullo, Vincenzo; Chirianni, Antonio; Pennica, Alfredo; Pasquazzi, Caterina; Segala, Daniela; Sarmati, Loredana
Link alla scheda completa:
Pubblicato in: